Raymond Stein
Contact Info
Office Hours
- Today
- 8:00AM - 5:30PM
Raymond Stein
About Raymond Stein
Dr. Raymond Stein is the Medical Director of the Bochner Eye Institute and one of the most experienced and respected ophthalmologists in North America. He has been honored with numerous awards from prestigious international medical organizations including the ‘Honour Award’ from both the American Academy of Ophthalmology and the Contact Lens Association of America, along with the ‘Innovators Award’ from the American Society of Cataract and Refractive Surgery. Dr. Stein also served as president of the Canadian Society of Cataract and Refractive Surgery.
Dr. Raymond Stein has been invited to lecture at numerous universities and medical conferences. and has published various journal and magazine articles, book chapters and books. With more than 200,000 successful eye surgeries performed, Dr. Stein has established himself as an expert and pioneer in refractive and implant surgery. As a testament to his exceptional surgical talents, he was chosen to serve as the chief eye surgeon for the W Network’s Style by Jury. He also serves as the editor of the prominent scientific journal, Clinical and Surgical Ophthalmology.
Dr. Stein began his career by completing a medical degree at the University of Toronto Medical School. Continuing his education, Dr. Raymond Stein performed an ophthalmology residency at the world-renowned Mayo Clinic and a fellowship at the Wills Eye Hospital in Philadelphia.
In addition to serving as the Medical Director at Bochner Eye Institute, Dr. Raymond Stein is the past Chief of Ophthalmology at the Scarborough Hospital in Toronto, is on the Board of Directors of the Foundation Fighting Blindness, and is the Cornea Consultant at the Mount Sinai Hospital. He also serves as an Associate Professor of Ophthalmology at the University of Toronto.
Dr. Raymond Stein is committed to providing high-quality care, including implantable contact lenses for patients with a variety of ophthalmologic needs. He offers a number of sophisticated refractive surgery procedures at Bochner Eye Institute utilizing the latest technologies and techniques.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.